Insider Selling: LifeStance Health Group (NASDAQ:LFST) Director Sells 79,630 Shares of Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) Director Robert Bessler sold 79,630 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $7.01, for a total value of $558,206.30. Following the completion of the sale, the director owned 1,382,175 shares of the company’s stock, valued at $9,689,046.75. The trade was a 5.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Robert Bessler also recently made the following trade(s):

• On Monday, December 15th, Robert Bessler sold 12,371 shares of LifeStance Health Group stock. The stock was sold at an average price of $7.00, for a total transaction of $86,597.00.

LifeStance Health Group Trading Down 0.6%

LFST stock traded down $0.04 on Tuesday, reaching $6.88. The company’s stock had a trading volume of 2,536,438 shares, compared to its average volume of 1,978,562. LifeStance Health Group, Inc. has a 12-month low of $3.74 and a 12-month high of $8.30. The firm has a market cap of $2.68 billion, a PE ratio of -229.33 and a beta of 1.13. The business has a fifty day simple moving average of $5.90 and a two-hundred day simple moving average of $5.34. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. LifeStance Health Group had a negative return on equity of 0.62% and a negative net margin of 0.67%.The business had revenue of $363.81 million during the quarter, compared to the consensus estimate of $355.06 million. During the same quarter in the prior year, the company earned ($0.02) earnings per share. The firm’s quarterly revenue was up 16.3% compared to the same quarter last year. As a group, research analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. BMO Capital Markets assumed coverage on shares of LifeStance Health Group in a report on Thursday, November 13th. They issued an “outperform” rating and a $8.00 target price for the company. BTIG Research lifted their price objective on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research note on Friday. Zacks Research lowered LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 5th. Barclays assumed coverage on shares of LifeStance Health Group in a research note on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 price objective for the company. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday. Two analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $8.83.

Institutional Trading of LifeStance Health Group

Several large investors have recently made changes to their positions in LFST. Jacobs Levy Equity Management Inc. purchased a new stake in shares of LifeStance Health Group in the first quarter valued at approximately $7,932,000. Adage Capital Partners GP L.L.C. increased its stake in shares of LifeStance Health Group by 43.8% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 230,000 shares of the company’s stock worth $1,532,000 after purchasing an additional 70,000 shares in the last quarter. Squarepoint Ops LLC boosted its stake in shares of LifeStance Health Group by 259.1% during the 2nd quarter. Squarepoint Ops LLC now owns 1,360,054 shares of the company’s stock worth $7,031,000 after purchasing an additional 981,349 shares during the last quarter. TD Asset Management Inc purchased a new stake in LifeStance Health Group in the 2nd quarter valued at about $780,000. Finally, Nuveen LLC purchased a new stake in LifeStance Health Group during the first quarter valued at about $6,928,000. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.